Concepedia

Publication | Open Access

SUVmax Predicts Disease Progression after Stereotactic Ablative Radiotherapy in Stage I Non-small Cell Lung Cancer

DOIFull Paper Access

20

Citations

21

References

2019

Year

Yoo-Kang Kwak, Hee Hyun Park, Kyu Hye Choi, Eunyoung Park, Soo Yoon Sung, Sea-Won Lee, Ji Hyun Hong, Hyo Chun Lee, Ie Ryung Yoo, Yeon‐Sil Kim
Cancer Research and Treatment

Abstract

Pre-SABR SUVmax demonstrated a predictive power in statistical analyses. Tumors with SUVmax above 6 at diagnosis were associated with inferior outcomes.

References

YearCitations

Page 1